RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX)

CUSIP: 75629V104

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Class A Common Stock
Shares outstanding
514,715,255
Total 13F shares
206,501,532
Share change
+30,452,225
Total reported value
$2,035,976,922
Put/Call ratio
72%
Price per share
$9.86
Number of holders
194
Value change
+$306,507,294
Number of buys
102
Number of sells
77

Quarterly Holders Quick Answers

What is CUSIP 75629V104?
CUSIP 75629V104 identifies RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) as of Q4 2023

As of 31 Dec 2023, RECURSION PHARMACEUTICALS, INC. - Class A Common Stock (RXRX) was held by 194 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 206,501,532 shares. The largest 10 holders included BAILLIE GIFFORD & CO, ARK Investment Management LLC, VANGUARD GROUP INC, Mubadala Investment Co PJSC, BlackRock Inc., STATE STREET CORP, FMR LLC, Kinnevik AB (publ), Nikko Asset Management Americas, Inc., and Sumitomo Mitsui Trust Holdings, Inc.. This page lists 194 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.